An observational study in Heart Failure and Hypertension, sponsored by Baxter Healthcare Corporation. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-12-30.
Sponsored by Baxter Healthcare Corporation · Observational
This study is designed to validate the use of the CoVa Monitoring System in subjects with implanted devices.
The study had the following objectives:
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 109 is below the median of 210 across 1,359 observational studies indexed under Hypertension.
Browse Hypertension studies →Baxter Healthcare Corporation is the lead sponsor of 78 studies on the registry; 1 is open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 3 (30%) have results posted.
Counted across the registry records on this site, refreshed daily.
Subjects will be from the Imperial Cardiac Clinic
Exclusion Criteria:
Subjects will have a pacemaker, implanted cardioverter-defibrillator, or ventricular assist device.
Number of Patients with Interference between implanted devices and CoVa Monitoring System
Time frame: One time for up to 15 minutes during a clinic visit for device interrogation
This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Baxter Healthcare Corporation